NCT06923774 European Real-World Registry for Use of the Ion Endoluminal System
| NCT ID | NCT06923774 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Intuitive Surgical |
| Condition | Pulmonary Nodule |
| Study Type | OBSERVATIONAL |
| Enrollment | 1,200 participants |
| Start Date | 2025-09-09 |
| Primary Completion | 2029-10 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 1,200 participants in total. It began in 2025-09-09 with a primary completion date of 2029-10.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The objective of this study is to collect collect real-world data for the Ion endoluminal system.
Eligibility Criteria
Inclusion Criteria: * Patient is aged 18 years or older at time of consent. * Patient is planned to undergo a lung lesion biopsy(s) and/or localization procedure(s) utilizing the Ion endoluminal system. * Patient is willing and able to give written informed consent for clinical study participation. Exclusion Criteria: * Patient is participating in an interventional research study or research study with investigational agents with an unknown safety profile that would interfere with participation in this study or study results. * Female patient that is pregnant or breast feeding as determined by standard site practices. * Patient is legally incapacitated or in a legal/court ordered institution or is part of a known vulnerable population, including but not limited to dependency on the sponsor, hospital or study doctor. * Patient is not willing to comply with post-procedure study participation requirements. * Investigator, in their professional opinion, has decided that it is in the patient's best interest to not participate in the clinical study.
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06923774 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Pulmonary Nodule. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06923774 currently recruiting?
Yes, NCT06923774 is actively recruiting participants. Contact the research team at IonEURegistry@intusurg.com for enrollment information.
Where is the NCT06923774 trial being conducted?
This trial is being conducted at Le Plessis-Robinson, France, Berlin, Germany, Hemer, Germany, Wiesbaden, Germany and 3 additional locations.
Who is sponsoring the NCT06923774 clinical trial?
NCT06923774 is sponsored by Intuitive Surgical. The trial plans to enroll 1,200 participants.